Andrew Mok CFA

Q: How accurate are Andrew Mok CFA's stock ratings?

About 61% of Andrew's ratings were profitable over a one-year hold, with an average return of +5.0% per rating, measured by 13Foresight from historical prices.

Q: How is Andrew ranked?

Andrew Mok CFA is ranked #1085 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Barclays

Wall Street Analyst

★★★☆☆

#1085

on 13Foresight · ranked by our own returns

61%

Success Rate

+4.8%

Average Return

46 of 75 calls profitable · +14.8% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 61% of Andrew Mok CFA's ratings turned a profit when each position was held for 1 year — averaging +4.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

121 Buy 76 Hold 25 Sell

Andrew's Stock Coverage 26 ratings · 2026-08-21

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
CNC Centene	Aug 18, 2026	BUY	Buy +11.8% avg upside 29 analysts	$80.00 24.73% Upside	-0.5%	·
AVAH Aveanna Healthcare Holdings	Aug 14, 2026	BUY	Buy -26.8% avg upside 18 analysts	$9.50 26.83% Downside	+0.0%	·
GMRS GMR Solutions, Inc. Class A	Aug 12, 2026	BUY	Strong Buy +35.1% avg upside 9 analysts	$16.00 13.19% Upside	+3.5%	·
RDNT Radnet	Aug 11, 2026	BUY	Strong Buy +6.4% avg upside 11 analysts	$65.00 15.64% Downside	+0.8%	·
DVA DaVita	Aug 11, 2026	HOLD	Buy -2.1% avg upside 17 analysts	$224.00 27.91% Upside	+1.0%	·
BKD Brookdale Senior Living	Aug 11, 2026	BUY	Strong Buy +18.1% avg upside 11 analysts	$17.00 43.99% Upside	-6.6%	·
ASTH Astrana Health	Aug 07, 2026	BUY	Strong Buy +49.5% avg upside 16 analysts	$53.00 36.76% Upside	+8.9%	·
OSCR Oscar Health	Aug 07, 2026	BUY	Buy -31.0% avg upside 16 analysts	$39.00 23.53% Upside	+14.8%	·
CVS CVS Health	Aug 06, 2026	BUY	Strong Buy +13.4% avg upside 39 analysts	$108.00 15.40% Upside	-2.7%	·
AGL Agilon Health	Aug 06, 2026	HOLD	Buy -28.3% avg upside 26 analysts	$111.00 19.62% Upside	+8.3%	·
EHC Encompass Health	Aug 06, 2026	BUY	Strong Buy -7.1% avg upside 22 analysts	$144.00 19.01% Upside	-2.2%	·
ADUS Addus Homecare	Aug 04, 2026	SELL	Strong Buy +6.7% avg upside 19 analysts	$96.00 20.45% Downside	-6.1%	·
ALHC Alignment Healthcare	Jul 31, 2026	HOLD	Strong Buy +64.6% avg upside 19 analysts	$16.00 23.68% Upside	-13.2%	·
CI Cigna	Jul 31, 2026	HOLD	Strong Buy +26.3% avg upside 29 analysts	$310.00 13.00% Upside	-1.3%	·
HUM Humana	Jul 31, 2026	HOLD	Buy +10.5% avg upside 34 analysts	$407.00 6.97% Upside	+4.6%	·
ACHC Acadia Healthcare	Jul 30, 2026	HOLD	Strong Buy +53.8% avg upside 17 analysts	$32.00 18.57% Upside	+9.6%	·
UHS Universal Health	Jul 28, 2026	HOLD	Buy +13.8% avg upside 22 analysts	$168.00 2.76% Downside	+2.3%	·
HCA HCA Healthcare	Jul 26, 2026	HOLD	Buy -0.2% avg upside 36 analysts	$387.00 4.68% Downside	+6.0%	·
THC Tenet Healthcare	Jul 24, 2026	BUY	Strong Buy -12.9% avg upside 27 analysts	$271.00 0.52% Downside	+15.9%	·
MOH Molina Healthcare	Jul 24, 2026	SELL	Hold +19.5% avg upside 26 analysts	$180.00 8.62% Downside	-1.2%	·
CYH Community Health	Jul 23, 2026	SELL	Sell +39.9% avg upside 18 analysts	$2.50 16.09% Downside	-7.9%	·
ELV Elevance Health	Jul 20, 2026	BUY	Strong Buy +13.7% avg upside 33 analysts	$457.00 15.30% Upside	+4.9%	·
UNH UnitedHealth	Jul 17, 2026	BUY	Strong Buy +18.1% avg upside 36 analysts	$441.00 14.56% Upside	-9.7%	·
PRVA Privia Health Group	May 26, 2026	HOLD	Strong Buy +50.3% avg upside 26 analysts	$24.00 13.31% Upside	-4.5%	·
LMRI Lumexa Imaging Holdings, Inc.	May 20, 2026	BUY	Strong Buy +60.0% avg upside 8 analysts	$9.00 22.93% Downside	+62.4%	·
SGRY Surgery Partners	May 12, 2026	HOLD	Strong Buy +61.5% avg upside 18 analysts	$14.00 0.43% Upside	+7.6%	·

🔒 21 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Andrew Mok CFA — Frequently Asked Questions

How accurate are Andrew Mok CFA's stock ratings?

Based on the calls 13Foresight could measure, about 61% of Andrew's ratings were profitable over a one-year hold, with an average return of +5.0% per rating, or +15.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Andrew ranked on 13Foresight?

Andrew Mok CFA is currently ranked #1085 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Andrew cover?

Andrew most recently has ratings on CNC, AVAH, GMRS, RDNT, DVA, BKD, ASTH, OSCR, CVS, AGL, EHC, ADUS and 14 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Andrew Mok CFA

Rating Distribution

Welcome to 13Foresight!